18 There was also a nonsignificant trend towards a higher rate of serious side effects during the use of infliximab, including infections, hypersensitivity reactions, autoimmune disease, and neoplasia. 17 While infliximab requires hospitalization for intravenous administration, adalimumab is administered subcutaneously, which is more comfortable for patients. 18 SO is a relatively rare and difficult disease to treat.
← all excerpts
Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab.
1
—
—